These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36658586)

  • 1. Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality.
    Rychter A; Miniszewska J; Góra-Tybor J
    Biopsychosoc Med; 2023 Jan; 17(1):1. PubMed ID: 36658586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.
    Hirji I; Gupta S; Goren A; Chirovsky DR; Moadel AB; Olavarria E; Victor TW; Davis CC
    Health Qual Life Outcomes; 2013 Oct; 11():167. PubMed ID: 24099272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden.
    Axelsson M; Brink E; Lundgren J; Lötvall J
    PLoS One; 2011 Mar; 6(3):e18241. PubMed ID: 21464898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The function of medication beliefs as mediators between personality traits and adherence behavior in people with asthma.
    Axelsson M; Cliffordson C; Lundbäck B; Lötvall J
    Patient Prefer Adherence; 2013; 7():1101-9. PubMed ID: 24174872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the five-factor model of personality traits and self-management attitude of patients with type 2 diabetes].
    Li ZM; Gao M; Chen XY; Sun XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):506-513. PubMed ID: 32541985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the Big Five personality traits and medication adherence in patients with cardiovascular disease: A cross-sectional study.
    Adachi T; Tsunekawa Y; Tanimura D
    PLoS One; 2022; 17(12):e0278534. PubMed ID: 36454925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
    Ferri C; Bianchini M; Bengió R; Larripa I
    Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between personality traits and adherence to treatment in patients with primary open-angle glaucoma in an African population.
    Abu EK; Antiri EO; Ocansey S; Ntodie M; Abokyi S; Abraham CH
    Clin Exp Optom; 2023 Jul; 106(5):509-515. PubMed ID: 35645224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trials.
    Jain P; Kantarjian H; Alattar ML; Jabbour E; Sasaki K; Nogueras Gonzalez G; Dellasala S; Pierce S; Verstovsek S; Wierda W; Borthakur G; Ravandi F; O'Brien S; Cortes J
    Lancet Haematol; 2015 Mar; 2(3):e118-28. PubMed ID: 26687797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report on personality and adherence to antibiotic therapy: a population-based study.
    Axelsson M
    BMC Psychol; 2013; 1(1):24. PubMed ID: 25566372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.
    Anderson KR; Chambers CR; Lam N; Yau PS; Cusano F; Savoie ML; Sheikh N
    J Oncol Pharm Pract; 2015 Feb; 21(1):19-25. PubMed ID: 24503243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia.
    Yood MU; Oliveria SA; Cziraky M; Hirji I; Hamdan M; Davis C
    Curr Med Res Opin; 2012 Feb; 28(2):213-9. PubMed ID: 22168217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the relationship between the big five personality characteristics and dietary habits among students in a Ghanaian University.
    Intiful FD; Oddam EG; Kretchy I; Quampah J
    BMC Psychol; 2019 Feb; 7(1):10. PubMed ID: 30795819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world analysis of tyrosine kinase inhibitor treatment patterns among patients with chronic myeloid leukemia in the United States.
    Henk HJ; Woloj M; Shapiro M; Whiteley J
    Clin Ther; 2015 Jan; 37(1):124-33. PubMed ID: 25467191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Personality Traits and Adherence to Antidepressants Assessed Through Self-Report, Electronic Monitoring, and Pharmacy Dispensing Data: A Pilot Study.
    Wouters H; Amin DF; Taxis K; Heerdink ER; Egberts AC; Gardarsdottir H
    J Clin Psychopharmacol; 2016 Oct; 36(5):465-71. PubMed ID: 27454894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of therapy adherence in imatinib resistant or intolerant patients with chronic myeloid leukemia receiving nilotinib or dasatinib in a real-world setting.
    Guérin A; Chen L; Wu EQ; Ponce de Leon D; Griffin JD
    Curr Med Res Opin; 2012 Jul; 28(7):1155-62. PubMed ID: 22738777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy.
    Smith BD; Liu J; Latremouille-Viau D; Guerin A; Fernandez D; Chen L
    Curr Med Res Opin; 2016 May; 32(5):817-27. PubMed ID: 26743563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of personality traits on medication adherence and self-care in patients with type 2 diabetes mellitus: The moderating role of gender and age.
    Hazrati-Meimaneh Z; Amini-Tehrani M; Pourabbasi A; Gharlipour Z; Rahimi F; Ranjbar-Shams P; Nasli-Esfahani E; Zamanian H
    J Psychosom Res; 2020 Sep; 136():110178. PubMed ID: 32623192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
    Al-Dewik NI; Morsi HM; Samara MM; Ghasoub RS; Gnanam CC; Bhaskaran SK; Nashwan AJ; Al-Jurf RM; Ismail MA; AlSharshani MM; AlSayab AA; Ben-Omran TI; Khatib RB; Yassin MA
    Clin Med Insights Oncol; 2016; 10():95-104. PubMed ID: 27721664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia.
    Seo HY; Ko TH; Hyun SY; Song H; Lim ST; Shim KY; Lee JI; Kong JH
    Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):735-743.e2. PubMed ID: 31563565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.